Fluoxetine has no marked effect on tic symptoms in patients with Tourette's syndrome: A double-blind placebo-controlled study

Journal of Child and Adolescent Psychopharmacology

Volumn 7, Issue 2, 1997, Pages 75-85

  Scahill, Lawrence ^a   Riddle, Mark A ^a   King, Robert A ^b   Hardin, Maureen T ^c   Rasmusson, Ann ^a   Makuch, Robert W ^a   Leckman, James F ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PLACEBO;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; HYPERACTIVITY; MALE; MICROCAPSULE; OBSESSION; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; SCHOOL CHILD; TIC;

EID: 0030810556     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.1997.7.75     Document Type: Article

References (48)

1. American Psychiatric Association, Committee on Nomenclature and Statistics: Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington (D.C.), American Psychiatric Association, 1987
2. Apter A, Ratzoni G, King RA, Weizman A, Iancu I, Binder M, Riddle MA: Fluvoxamine open-label treatment of adolescent inpatients with obsessive-compulsive disorder or depression. J Am Acad Child Adolesc Psychiatry 33:342-348, 1994
3. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 4:561-563, 1961
4. Como PG: Obsessive-compulsive disorder in Tourette syndrome. In: Behavioral Neurology of Movement Disorders. Advances in Neurology, Volume 65. Edited by Weiner WJ, Lang AE. New York, Raven, 1995, pp 281-291
5. Como PG, Kurlan R: An open-label trial of fluoxetine for obsessive-compulsive disorder in Gilles de la Tourette's syndrome. Neurology 41:872-874, 1991
6. Delgado PL, Goodman WK, Price LH, Heninger GR, Charney DS: Fluvoxamine/pimozide treatment of concurrent Tourette's and obsessive-compulsive disorder. Br J Psychiatry 157:762-765, 1990
7. DeVeaugh-Geiss J, Moroz G, Biederman J, Cantwell D, Fontaine R, Griest JH, Reichler R, Katz R, Landau P: Clomipramine in child and adolescent obsessive-compulsive disorder: A multicenter trial. J Am Acad Child Adolesc Psychiatry 31:45-49, 1992
8. Fennig S, Naisberg-Fennig S, Pato M, Weitzman A: Emergence of symptoms of Tourette's syndrome during fluvoxamine treatment of obsessive-compulsive disorder. Br J Psychiatry 164:839-841, 1994
9. Flament M, Rapoport JL, Berg CZ, Sceery W, Kilts C, Mellstrom B, Linnoila M: Clomipramine treatment of childhood obsessive-compulsive disorder. Arch Gen Psychiatry 42:977-983, 1985
10. Foa EB, Emmelkamp PMG: Failures in Behavior Therapy. New York, John Wiley & Sons, 1983
11. Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS: Efficacy of fluvoxamine in obsessive-compulsive disorder. Arch Gen Psychiatry 46:36-44,. 1989a
12. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischman RL, Hill CL, Heninger GR, Charney DS: The Yale-Brown Obsessive Compulsive Scale: I. Development, use, and reliability. Arch Gen Psychiatry 46:1006-1011, 1989b
13. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Chamey DS: The Yale-Brown Obsessive Compulsive Scale: II. Validity. Arch Gen Psychiatry 46:1012-1018, 1989c
14. Hamilton M: The assessment of anxiety states by rating. Br J Med Psychol 32:50-55, 1959
15. Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychology 6:278-296, 1967
16. Holzer JC, Goodman WK, McDougle CJ, Baer L, Boyarsky BK, Leckman JF, Price LH: Obsessive-compulsive disorder with and without a chronic tic disorder: A comparison of symptoms in 70 patients. Br J Psychiatry 164:469-473, 1994
17. Koch G: The use of non-paramentric methods in the statistical analysis of the two-period change-over design. Biometrics 28:577-584, 1972
18. Kovacs M: The Children's Depression Inventory (CDI). Psychopharmacol Bull 21:995-1000, 1985
19. Kurlan R, Como PG, Deeley C, McDermott M, McDermott MP: A pilot controlled study of fluoxetine for obsessive-compulsive symptoms in children with Tourette's syndrome. Clin Neuropharmacol 16:167-172, 1993
20. Leckman JF, Sholomskas D, Thompson WD, Belanger A, Weissman MM: Best estimate of lifetime psychiatric diagnosis. Arch Gen Psychiatry 39:879-883, 1982
21. Leckman JF, Towbin KE, Ort SI, Cohen DJ: Clinical assessment of tic disorder severity. In: Tourette's Syndrome and Tic Disorders. Edited by Cohen DJ, Bruun RD, Leckman JF. New York, John Wiley & Sons, 1988, pp 55-78
22. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen DJ: The Yale Global Tic Severity Scale: Initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 28:566-573, 1989
23. Leckman JF, Hardin MT, Riddle MA, Stevenson J, Ort SI, Cohen DJ: Clonidine treatment of Gilles de la Tourette syndrome. Arch Gen Psychiatry 48:324-328, 1991
24. Leckman JF, Walker DE, Goodman WK, Pauls DL, Cohen DJ: "Just right" perceptions associated with compulsive behaviors in Tourette's syndrome. Am J Psychiatry 151:675-680, 1994a
25. Leckman JF, Goodman WK, North WG, Chappell PB, Price LH, Pauls DL, Anderson GA, Riddle MA, McSwiggan-Hardin MT, McDougle CJ, Barr LC, Cohen DJ: Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Arch Gen Psychiatry 51:782-792, 1994b
26. Leckman JF, Goodman WK, Anderson GA, Riddle MA, Chappell PB, McSwiggan-Hardin MT, McDougle CJ, Scahill L, Ort SI, Pauls DL, Cohen DJ, Price LH: Cerebrospinal fluid amines in obsessive-compulsive disorder, Tourette's syndrome and healthy controls. Neuropsychopharmacol 12:73-86, 1995a
27. Leckman JF, Grice DE, Barr LC, deVries ALC, Martin C, Cohen DJ, Goodman WK, Rasmussen SA: Tic-related vs. non-tic-related obsessive-compulsive disorder. Anxiety 1:208-215, 1995b
28. Leonard HL, Swedo SE, Rapoport JL, Koby EV, Lenane MC, Cheslow DL, Hamburger SD: Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. Arch Gen Psychiatry 46:1088-1092, 1989
29. Leonard HL, Swedo SE, Lenane MC, Rettew DC, Cheslow DL, Hamburger SD, Rapoport JL: A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder. Arch Gen Psychiatry 48:922-927, 1991
30. Levine J, Schooler N: Strategies for analyzing side effects data from SAFTEE. Psychopharmacol Bull 22:343-381, 1986
31. Lombroso PJ, Scahill L, Chappell PB, Pauls DL, Cohen J, Leckman JF: Tourette's syndrome: A multigenerational neuropsychiatric disorder. In: Behavioral Neurology of Movement Disorders. Advances in Neurology, Volume 65. Edited by Weiner WJ, Lang AE. New York, Raven, 1995, pp 305-331
32. March JS, Leonard HL, Swedo SE: Pharmacotherapy of obsessive-compulsive disorder. Child Adolesc Psychiatric Clinics North Am 4:217-236, 1995
33. McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH: Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder: A double-blind, placebo-controlled study in patients with and without tics. Arch Gen Psychiatry 51:302-308, 1994
34. Miguel EC, Coffey BJ, Baer L, Savage CR, Rauch SL, Jenike MA: Phenomenology of intentional repetitive behaviors in obsessive-compulsive disorder and Tourette's disorder. J Clin Psychiatry 56:246-255, 1995
35. Pauls DL, Raymond CL, Stevenson JM, Leckman JF: A family study of Gilles de la Tourette syndrome. Am J Human Genetics 48:154-163, 1991
36. Pauls DL, Alsobrook JP, Goodman WK, Rasmussen S, Leckman JF: A family study of obsessive-compulsive disorder. Am J Psychiatry 152:76-84, 1995
37. Pigott TA, Pato MT, Bernstein SE, Grover GN, Hill JL, Toliver TJ, Murphy DL: Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder: Behavioral and biological results. Arch Gen Psychiatry 47:926-932, 1990
38. Pocock SJ: Clinical Trials: A Practical Approach. New York, John Wiley & Sons, 1983
39. Poznanski EO, Grossman JA, Buchsbaum Y, Banegas M, Freeman L, Gibbons R: Preliminary studies of the reliability and validity of the Children's Depression Rating Scale. J Am Acad Child Psychiatry 23:191-197, 1984
40. Ratzoni G, Harmesh H, Brandt N, Lauffer M, Munitz H: Clomipramine efficacy for tics, obsessions, and compulsions in Tourette's syndrome and obsessive-compulsive disorder: A case study. Biol Psychiatry 27:95-98, 1990
41. Reynolds CR, Richmond B: Revised Children's Manifest Anxiety Scale (RCMAS) Manual. Los Angeles, Western Psychological Services, 1987
42. Riddle MA, Leckman JF, Hardin MT, Anderson GM, Cohen DJ: Fluoxetine treatment of obsessions and compulsions in patients with Tourette's syndrome [letter]. Am J Psychiatry 145:1173-1174, 1988
43. Riddle MA, Hardin MT, King RA, Scahill L, Woolston JL: Fluoxetine treatment of children and adolescents with Tourette's and obsessive compulsive disorder: Preliminary clinical experience. J Am Acad Child Adolesc Psychiatry 29:450-48, 1990
44. Riddle MA, King RA, Hardin MT, Scahill L, Ort SI, Leckman JF: Behavioral side effects of fluoxetine in children and adolescents. J Child Adolesc Psychopharmacol 1:193-198, 1991
45. Riddle MA, Scahill L, King RA, Hardin MT, Ort SI, Leckman JF: Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive compulsive disorder. J Am Acad Child Adolesc Psychiatry 31:1062-1069, 1992
46. Scahill L: Contemporary approaches to pharmacotherapy in Tourette syndrome and obsessive-compulsive disorder. J Child Adolesc Psychiatric Nursing 9:27-43, 1996
47. Scahill L, Riddle MA, Hardin MT, Ort SI, King RA, Goodman WK, Leckman JF: Children's Yale Brown Obsessive Compulsive Scale: Reliability and validity. J Am Acad Child Adolesc Psychiatry 36:844-852, 1997
48. Walkup JT, Scahill L, Riddle MA: Disruptive behavior, hyperactivity, and learning disorders in children with Tourette's syndrome. In: Behavioral Neurology of Movement Disorders. Advances in Neurology, Volume 65. Edited by Weiner WJ, Lang AE. New York, Raven, 1995